Finolex Q1: Margin stability & capex intensity in focus amid muted demand
Finolex reports Q1 FY27 results on August 6 into a Street consensus expecting topline & profit weakness (revenue ~₹954 Cr, PAT ~₹49 Cr) due to agri-pipe demand softness and monsoon seasonality. But 14-analyst coverage sees a full-year recovery thesis: FY27 PAT growth 15–20%, with consensus target ₹210.79 (27% upside). The print will hinge on margin resilience, demand tone, and dividend sustainability.
What to expect: the on-plan picture
Finolex is a capital-intensive pipes & fittings player in an infrastructure-led industrials space. With no prior Q1 P&L disclosed, the quarter will be read against the FY26 close (board-approved May 26, 2026) and Street consensus on topline/profit. The consensus view: Q1 faces headwinds—revenue expected ~₹954 Cr (-8.5% YoY) and PAT ~₹49 Cr (-50% YoY)—reflecting agri-pipe demand weakness and monsoon seasonality. But the Street sees FY27 full-year PAT growth of 15–20% (recovery thesis). Focus on: topline momentum (order intake, demand signals) and margin resilience (EBITDA sustainability, working capital, capex guidance).
~₹954 Cr
Street expect -8.5% YoY vs ₹1,043 Cr in Q1 FY26 (reflects agri-pipe demand weakness, monsoon headwinds)
~₹49 Cr
Street expect -50% YoY vs ₹98 Cr in Q1 FY26; but FY27 full-year PAT growth ~15–20% recovery thesis on demand normalization
15–17%
Q4 FY26 was 25.3% (inflated by PVC spreads & inventory MTM gains); FY27 expected to moderate to sub-15% per analyst consensus
₹210.79
27% upside from ₹165.79; Jefferies raised to ₹280, Anand Rathi/BOB at ₹240, IDBI/Prabhudas at ₹207
Strong print: Revenue growth >6% with OPM holding above 15%, net margin intact, and management commentary affirming FY27 capex plans without guidance cuts. Weak print: Revenue flat or negative, OPM compression below 14% (input cost or working capital stress), or any guidance downside surprise.
On track? The guidance lens
Finolex has not issued a formal FY27 guidance. The board approved FY26 audited results on May 26, 2026, recommending a final dividend of ₹2 (100%) plus a special dividend of ₹0.75 (37.5%)—a total of ₹2.75 per share, signaling shareholder confidence and capital return discipline. Q1 will be the first test of whether the FY26 trajectory (which saw a special dividend) is sustainable or a one-off. Watch management's tone on demand environment, capex phasing, and working capital needs.
What the Street says
Since the last quarter: the filings scan
Jul 29, 2026
Board convenes Aug 6 to approve Q1 FY27 audited financial results (standalone & consolidated)
Board Meeting Notice
Jul 1, 2026
Window closed for designated persons re: Q2 FY27 results; effective until 48 hours post-announcement
Trading Window
May 26, 2026
Board approved audited FY26 results; recommended final div ₹2 + special div ₹0.75 = ₹2.75/share (137.5%)
FY26 Results & Dividend
May 26, 2026
Cost Auditor: S. R. Bhargave & Co. | Internal Auditor: M M Nissim & Co LLP for FY27
Auditor Reappointment
All recent filings are routine—no insider buying/selling, pledges, or M&A signals. The special dividend (37.5% of base) is worth flagging as a capital return; watch whether management sustains this payout policy or reverts to the base ₹2 in FY27. Ownership remains stable: promoter 52.47%, FII 5.87%, DII 12.79% as of Q4 FY26. No material promoter churn or block deals evident.
Watch list
1 · Margin arithmetic — input costs & capex phase
Operating margin is the hinge. If OPM slips below 14% or management signals cost headwinds, it signals working capital stress or demand softness. Any capex guidance update (FY26 was silent) will reset the ROIC narrative.
2 · Demand tone — infrastructure capex cycle
Management commentary on order intake, pipeline, and end-market sentiment (roads, water, utilities) matters more than Q1 revenue alone. Q1 is seasonally softer; watch whether the company still sees full-year demand tailwinds.
3 · Dividend & capital allocation policy
The special dividend signals confidence, but sustainability hinges on cash generation. Q1 will show whether FY26's capex needs and cash position permit similar payouts in FY27—or if the special was a one-time.
Finolex reports Q1 FY27 into a consensus that prices in weakness (revenue ₹954 Cr YoY, PAT ₹49 Cr YoY) but bets on full-year recovery (FY27 PAT +15–20%). The Stock is down 17% from ATH amid ROCE/ROE headwinds (9.3% ROCE, 12% ROE vs peers). Beat: revenue >₹954 Cr AND PAT >₹49 Cr + management reaffirms FY27 capex without guidance cut + dividend guidance intact → upside to ₹280 (Jefferies). Miss: revenue <₹900 Cr OR PAT <₹40 Cr + margin miss + guidance cuts → downside risk. Watch agri-pipe demand tone, PVC spread sustainability, and capex returns narrative on the call.
Margin held, but the volume collapse is real—and the recovery is untested
EBITDA margin held at 12% despite a 27% volume drop, masking competitive underperformance and raising hard questions about margin quality. Management deferred full-year growth guidance, citing volatility—a retreat from prior "higher single to lower double-digit" expectations.
₹114.5 Cr
+16.7% YoY
-56.2%
Severe seasonal decline
12%
+300 bps YoY, but realization lagged peers
-27% YoY
vs industry -8–10%; share fell 27%→22%
The tension: margin held, but at what cost?
The headline is clean—EBITDA margin up 300 basis points to 12% despite volume collapsing 27%. The problem is in the details. On a quarter-on-quarter basis, realization rose just 1%, while competitors Prince and Supreme saw 7–9% gains. The PVC-EDC spread compressed from $522 to $501, yet margin expanded. Management cited realization-driven outperformance and cost control, but declined to quantify inventory gains or losses, citing it was "too early to report." That deflection signals the margin gain may not be repeatable. Moreover, the underperformance versus peers—volume down 27% against an industry decline of 8–10%—points to competitive share loss, not a PVC cycle play.
Market share: the elephant on the call
Finolex's share versus the top-6 competitors fell from 27% in FY23 to 22% in FY26. Q1 exacerbated this: volume down 27% while peers declined 8–10%. When pressed, management acknowledged the gap but deflected—citing Finolex's "pure-play" PVC positioning and higher agri exposure (69% of mix) versus diversified peers in CPVC and plumbing. That's a diagnosis, not a fix. The company's 50-50 agri-to-non-agri rebalancing goal is a 4–5 year play; in the near term, it's exposed to both structural agri weakness and competitive non-agri players pulling volume away. No concrete win-back plan was articulated on the call.
So that's the primary reason what we see as part of the reason for lower volumes for us. If I look at top 6 companies, our share for the full year FY26 was about 22%, okay? And when we look at market share, we should look at it over a longer period of time and not on a quarter-to-quarter basis.
Margin expansion despite 27% volume decline due to realization and cost control
EBITDA margin 12% (+300 bps YoY) despite volume -27%. But QoQ realization only +1% vs peers +7–9%. PVC-EDC spread down $522→$501. Inventory gain/loss withheld. Margin quality unclear.
Overstated
Market share stable vs top-6 competitors over longer period
Share declined 27% (FY23) → 22% (FY26). Q1 volume -27% vs industry -8–10%, worsening the loss. Management acknowledged but offered no recovery plan.
Contradicted
Structural demand drivers remain intact; medium-term confidence justified
Agri (69%) down 27% YoY; non-agri (31%) down 24%. JJM 2.0 allocation (₹67k Cr) lower than JJM 1.0. Post-MIP recovery early and unproven. Confidence hinges on untested destocking narrative.
Supported but unproven
What changed on this call
Guidance retreat: Prior call promised "higher single to lower double-digit" FY27 growth. Q1 delivered -15% revenue. Management now cites "too much volatility" and has deferred full-year guidance, offering only a vague "flattish to slight plus YoY" for H1. That's a step back in confidence, though transparently communicated. Sub-15% EBITDA margin reaffirmed despite Q1 weakness. At 12% delivered, H2 average ~14–15% is needed to stay sub-15%—achievable but dependent on volume recovery and stable PVC pricing. PVC price floor via MIP and customs duty: Mid-July intervention (minimum import price + customs duty withdrawal) set a pricing floor. Management cited July as "the best month of four," signaling early restocking and destocking recovery. This is a structural positive if it sticks, though unquantified in the report. Market share loss acknowledged: 27%→22% vs top-6 is now openly discussed, but without a concrete win-back plan. Management's message: "look over a longer period." The street heard: we're losing share and aren't ready to fight back yet.
How the market is reading it
The post-result decline held steady and deepened. Day 1: -4.02%, day 3: -5.05%, day 5: -5.49%. The initial shock did not fade—it worsened, signaling the street's own verdict that margin quality is suspect and the recovery narrative is unproven. The stock sits at ₹159.24 as of 2026-08-14, down 20.54% from its all-time high, below its 20-day, 50-day, and 200-day moving averages (₹163.79, ₹168.96, ₹174.45 respectively). RSI at 42.6 is neutral, not oversold—there's no technical capitulation to suggest a floor. Ownership flows are flat: FII down 2 basis points, DII down 144 basis points, promoter unchanged. Institutional money is neither fleeing nor arriving; this is a story the market has already priced in as broken.
EBITDA margin held at 12% despite 27% volume fall; cost discipline proven
Market share fell from 27% (FY23) to 22% (FY26); Q1 underperformance vs peers worsened loss
₹2,636 Cr cash and 10–12% organic growth headroom; no capex expansion plan disclosed
Post-MIP price floor in place; July uptick early positive, but unquantified and unproven
Realization QoQ only +1% vs peers +7–9%; potential inventory gain withheld—margin quality unclear
Agri concentration at 69%; both agri and non-agri down 24–27%, signaling broad competitive pressure
VCM supply constraints (monsoon, Middle East force majeure) limit H1 PVC output; EDC line uninterrupted
Full-year growth guidance deferred; prior "higher single to lower double-digit" target abandoned after Q1 miss
Competitive market share loss (27%→22% vs top-6; Q1 -27% volume vs industry -8–10%)
HighShare erosion is now structural, not cyclical. Agri mix alibi deflects from real competitive loss in non-agri/CPVC to pure-play rivals. No recovery plan articulated; 4–5 year rebalancing is too slow.
Margin quality and sustainability (realization lag vs peers; inventory gains withheld)
HighEBITDA margin up 300 bps despite volume collapse and spread compression is anomalous. QoQ realization only +1% vs peers +7–9% signals cost/inventory benefit. If inventory reverses, margin contracts fast. Credibility damage if Q2 disappoints.
Agri segment concentration and structural weakness (69% of mix, down 27% YoY)
HighBoth agri and non-agri fell 24–27%; agri is no longer a cyclical headwind but a structural drag. JJM 2.0 lower than 1.0; monsoon/weather risk ever-present. Pure-play positioning is a burden, not a moat.
VCM supply constraints (monsoon, Middle East force majeure limiting H1 production)
MediumVCM line (half of capacity) offline May–Sep; EDC line uninterrupted. Limits near-term PVC output and margin. Middle East situation "unpredictable" per management. Supply recovery in Q3+ necessary for full upside.
Guidance deferral and forecast uncertainty (H2 outlook deferred pending Q2 data)
MediumPrior "higher single to lower double-digit" guidance now abandoned. "Too much volatility" signals management loss of confidence. If H1 stalls or Q2 disappoints, stock re-rates lower. MIP floor should have allowed some guidance hold—retreat looks defensive.
Channel inventory and destocking cycle (post-April correction; July uptick unquantified)
MediumChannel near-normal per management, but July stocking tied to price-floor expectations. If demand normalizes slower than expected or if price floor breaks, volume stumbles. Unquantified data limits conviction.
1 · Q2 volume traction and market share stabilization
Post-MIP floor should enable restocking and volume recovery. Concrete monthly data (August onward) will test management's "flattish to slight plus H1" forecast. Any sign that share loss is accelerating (vs peers -8–10% in next cycle) triggers a downgrade.
2 · Margin sustainability without inventory gains
Q2 EBITDA margin must show if Q1's 12% is structural or inventory-aided. If margin compresses toward 10–11% despite volume recovery, the cost-control story collapses. Realization pass-through (relative to peers) is the tell.
3 · Capital deployment and CPVC strategy
₹2,636 Cr cash with no major capex plan looks defensive. Any announcement of CPVC capacity expansion (7% of current volume, strategic goal 10–20%) or shareholder returns would signal management confidence. Board decision deferred; watch for update in H2 guidance or next call.
Finolex's Q1 is a study in the gap between headline and organic profit. Margin held, but realization lagged peers and inventory gains were deferred—raising hard questions about Q2. Volume collapsed 27% versus an industry decline of 8–10%, and management offered no roadmap to regain market share in a 4–5 year timeframe it hasn't committed to yet. The post-MIP price floor is real, and July's uptick is a green shoot—but early.
This is a steady-execution story, not a recovery step-change. Cost control and the brand are intact; the problem is competitive headwinds in agri and structural underperformance in non-agri. Until Q2 proves margin can stick without inventory help and volume stabilizes, the stock will trade on caution. The number to track from here is EBITDA margin in Q2—if it drops below 11%, the thesis breaks.
Finolex Q1 FY27: consol PAT +17% YoY on margin rebound, revenue down 15%
PAT +16.67% YoY · revenue -15.3% · margins expanding · beat vs street
₹883.58 Cr
-15.3% YoY
₹114.52 Cr
+16.67% YoY
11.94%
+3.1pp YoY
₹1.85
Finolex Industries' consolidated Q1 FY27 (quarter ended June 30, 2026) revenue fell 15.3% YoY to ₹883.58 Cr (from ₹1,043.15 Cr) and was down 32.7% sequentially from Q4 FY26's ₹1,313.88 Cr, undershooting even the bearish ~₹954 Cr street estimate (Univest preview, -8.5% YoY). Consolidated PAT, however, rose 16.7% YoY to ₹114.52 Cr (from ₹98.16 Cr) and beat the street's ~₹49 Cr estimate (-50% YoY) by a wide margin — the quarter's real surprise is that profitability held up well above what the Street had priced in for a period flagged for PVC price volatility. Against management's own guidance from the Q4 FY26 call — FY27 revenue growth in the higher-single to lower-double-digit range, alongside a warning that short-term demand was being hit by PVC price volatility (with May showing improvement) — this quarter's topline decline is consistent with, not a break from, what management had already flagged; the demand softness materialised as guided even if the outright decline is steep.
Q1 FY-2027 vs prior quarters
Margin recovery drove the profit beat: consolidated NPM expanded to 12.96% from 8.86% a year ago, and operating margin (EBITDA excluding other income, computed) improved to roughly 12.06% from 8.97% YoY, a normalisation from FY26's depressed cost-price spreads. Sequentially both metrics compressed sharply from Q4 FY26's seasonal peak (NPM 19.35%, OPM 25.27%), consistent with Q4 being the stronger pre-monsoon quarter for pipe demand and Q1 facing monsoon-linked construction slowdown. Tax expense fell to ₹33.28 Cr from ₹89.76 Cr in Q4, aided by a ₹7.29 Cr deferred tax credit versus a charge previously. This margin path — moderating well below FY26's highs — tracks management's stated target of a sub-15% full-year EBITDA margin.
The stock went into the print at ₹171.31, up 3.8% over the past month of trading.
What the summary numbers don't show
Consolidated PAT ₹114.52 Cr, up 16.7% YoY (₹98.16 Cr) but down 56.2% QoQ from Q4's seasonally strong ₹261.25 Cr.
Results approved at the August 6, 2026 board meeting — 45th AGM scheduled for September 22, 2026.
Management anticipates moderating EBITDA margins from current highs, targeting a sub-15% level on a full-year basis. While short-term demand was impacted by PVC price volatility, May showed improvement, with projections for FY27 growth in the higher single to lower double-digit range. The company is strategically incre
— This quarter: met
Standalone PAT of ₹107.41 Cr on the same ₹883.58 Cr revenue sits just below the consolidated ₹114.52 Cr; the gap is a ₹0.24 Cr share of associate profit (Finolex Plasson Industries and Pawas Port) plus a lower consolidated tax charge — no material divergence in the underlying story between the two bases. The board separately recommended dividends and reappointed cost/internal auditors earlier in the quarter, both routine governance items rather than result drivers; the standalone number includes ₹5.55 Cr of PAT from the Finolex Employees' Welfare Trust, a recurring item flagged by the auditor rather than a one-off.
W1
Revenue recovery: management said 'May showed improvement' — watch if Q2 FY27 volumes move back toward the guided FY27 high-single/low-double-digit growth after Q1's 15.3% YoY decline.
W2
Margin sustainability: consolidated OPM ~12.06% this quarter vs. management's guided sub-15% full-year EBITDA margin ceiling — track whether spreads hold or slip further.
W3
Agri/non-agri mix: management's 4-5 year target of a 50-50 agri/non-agri split — watch for segment disclosures on progress, not separately reported this quarter.
Margin hold masks volume rout; recovery narrative untested
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Maintained sub-15% EBITDA margin guidance. Missed FY27 'higher single to lower double-digit' growth in Q1 (-15% revenue). July uptick unquantified; H2 guidance deferred.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Finolex held EBITDA margins at 12% despite 27% volume collapse, signaling cost control and realization gain. However, margin quality is unclear (realization lag vs peers, potential inventory drag not quantified). Market share loss to 22% (from 27% in FY23) and volume underperformance vs peers (~8-10% industry decline) signal competitive pressure in high-agri mix (69%). Post-MIP recovery is early and unproven. Key risk: agri segment weakness and VCM supply constraints limiting H1 upside.
₹883.6 Cr
Revenue · −15.3% YoY₹114.5 Cr
Reported PAT · +16.7% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Margin expansion despite 27% volume decline due to realization and cost control
OVERSTATEDEBITDA margin 12% (up 300bps YoY) despite volume -27%. PVC-EDC spread down $522→$501. Realization Q-o-Q only +1% vs peers +7-9%, suggesting potential inventory gain not fully disclosed.
Market share stable vs top-6 competitors over longer period
MISSShare declined from 27% (FY23) to 22% (FY26) vs top-6; Q1 volume decline 27% vs industry ~8-10%. Management acknowledged but deflected, citing non-agri mix difference and pure-play positioning.
Structural demand drivers remain intact, medium-term confidence justified
METAgri segment (69% of mix) down 27% YoY; non-agri down 24%. JJM 2.0 allocation (₹67k Cr) lower than JJM 1.0. No concrete new contracts or order book cited. Confidence hinges on post-MIP recovery, yet untested.
Earnings quality
What changed since the last call
Volume guidance deferred; full-year outlook uncertain
DowngradePrior call: 'higher single to lower double-digit growth FY27.' Q1 shows -15% revenue, -27% volume. Management now cites 'too much volatility' and defers H2 guidance pending Q2 trends. Realistic but cautionary.
Margin guidance maintained despite Q1 miss
NeutralSub-15% EBITDA target held. Q1 delivered 12% EBITDA, implying H2 capex pressure or volume recovery needed to avoid miss. Management hedged with 'geopolitical uncertainty' caveat.
PVC price floor set; channel destocking narrative
UpgradeCustoms duty withdrawal + MIP (minimum import price) on PVC resin imposed mid-Jul. Sets floor, reduces volatility. July volume 'good uptick' post-announcement. Positive structural shift vs Q1 price swings.
Market share 27%→22% acknowledged but downplayed
DowngradeShare vs top-6 fell from 27% (FY23) to 22% (FY26). Q1 volume -27% vs peers -8-10% worsens loss. Management blamed agri exposure and pure-play positioning; did not commit to recovery plan.
The Q&A
Analysts pressed hard on 27% volume collapse vs peers, market share loss (27%→22%), margin quality (realization only +1% QoQ, potential inventory gain), and CPVC capex inertia despite ₹2.6T cash. Management defended agri mix attribution and deferred capex to Board. Tone evasive on month-by-month data and margin drivers; ended call emphasizing 'structural demand' rather than addressing share loss directly.
Volume vs peers — Shravan Shah, Dolat Capital
PartialAgri segment (dominance) more affected than plumbing/non-agri. April had sharp PVC price correction (₹96→₹82/kg), channel destocking. Q-o-Q realization +15% YoY, peers in same range. Prices came down in April, impacting realization.
Market share decline — Sneha Talreja, Nuvama
DodgedFY26 share 22%, Q1 unchanged vs FY26 if full data available. Should view over longer term, not quarter-to-quarter. Pushing penetration in underrepresented areas. Finolex is pure-play PVC; peers have other polymers.
Margin drivers — Sonali, Jefferies
PartialRealization-driven, costs range-bound. Operating performance top-line driven. Backward integrated cost advantage (VCM procurement timing) provides cushion vs peers.
Channel inventory — Sonali, Jefferies
AnsweredNear normal now. July stocking occurred on price rise expectation; now price floor is set (MIP), so demand should stabilize and restocking moderate.
CPVC capex with ₹2.6T cash — Shravan Shah, Dolat Capital
DodgedAlready have sufficient CPVC extrusion capacity. CPVC is ~7-8% of market, our share matches industry. Capex plans guided by Board; ongoing discussion on deployment vs shareholder returns.
Full-year volume outlook — Shravan Shah, Dolat Capital
PartialToo early to say. Only Q1 completed, much volatility. Will give guidance after seeing Q2 trends. July was best month of 4; if sustained, could see 'flattish, not slight plus' H1 YoY.
Margin guidance sustainability — Anu Parakh, Anand Rathi
PartialHolding back given volatility in Q1. Sub-15% remains target. Let's see how quarter progresses with geopolitical uncertainty before revising.
VCM supply outlook — Anu Parakh, Anand Rathi
AnsweredLimited due to Middle East force majeure. Northeast Asia feedstock constrained. Monsoon (May-Sep) jetty limitations prevent VCM import anyway. Efforts ongoing; situation 'unpredictable.' Spread dynamics also a factor.
Guidance
FY27 growth: higher single to lower double-digit (prior call)
LowQ1 result -15% revenue; management no longer quantifies FY27 guidance, cites volatility. Implies prior target at risk; requires strong H2 recovery to meet lower end of range.
Sub-15% EBITDA margin for FY27 maintained
MediumQ1 delivered 12% EBITDA, implying H2 average ~14-15% needed to stay sub-15%. Dependent on volume recovery and stable PVC pricing post-MIP floor. Geopolitical uncertainty noted.
₹125-200 Cr capex range maintained for organic growth and debottlenecking
HighStated as 'short-term macro does not impact long-term capex plans.' No major greenfield/brownfield announced; incremental capacity via debottlenecking and higher-capacity extruder swaps.
Risks the call surfaced
Competitive market share loss
HighMarket share fell from 27% (FY23) to 22% (FY26) vs top-6; Q1 volume -27% vs industry ~8-10% decline. Agri segment (69% of mix) underperforming plumbing/CPVC (higher-growth, higher-margin segments). Risk of continued share loss if agri remains weak.
Realization and margin quality
MediumQ1 EBITDA margin 12% (up 300bps) despite volume -27% and PVC-EDC spread down ($522→$501). Q-o-Q realization only +1% vs peers +7-9%, contradicting margin expansion magnitude. Management cites realization and cost control but declines to quantify inventory gains/losses, raising doubt.
VCM supply constraints
MediumMiddle East producers under force majeure; Northeast Asia feedstock constrained. Monsoon jetty (May-Sep) prevents VCM import. Limits VCM-line PVC output for 4-5 months; EDC line (half capacity) continues without interruption. Risk: reduced PVC production and margin if VCM supply does not recover by Q3.
Agri segment concentration and structural weakness
HighAgri segment down 27% YoY, non-agri down 24% — both fell despite 69-31 mix emphasis. Structural trend: competitors have diversified into CPVC, fittings, and non-agri earlier. Finolex's 50-50 target (4-5 years) is slow and at risk if agri demand structurally shifts.
Guidance deferral and uncertainty
MediumPrior FY27 guidance: 'higher single to lower double-digit growth.' Q1: -15% revenue. Management now cites 'too much volatility' and defers full-year guidance pending Q2 trends. July 'good uptick' unquantified. Risk: market may reprice if H2 trajectory disappoints or stalls.
Management
Score 5/10. Moderate clarity but defensive on market share loss and margin drivers. Deferred month-by-month volume data, withheld inventory gain/loss quantification, and deflected CPVC capex decisions to Board. Transparent on PVC dynamics and channel trends but guarded on execution gaps vs peers. Mixed. Maintained sub-15% EBITDA margin guidance (met). Missed FY27 'higher single to lower double-digit' growth in Q1 (-15% revenue). Volume declined 27% vs peers -8-10%, signaling underperformance. Market share fell 27%→22% over 3 years. July uptick unproven; H1 outlook 'flattish to slight plus' still implies near-zero FY26 exit parity.
1 · Q2 FY27 (Aug-Sep)
PVC price stabilization post-MIP; channel restocking and volume recovery traction
2 · H2 FY27 (Oct-Mar)
JJM 2.0 rollout; seasonal agri demand (Rabi), realization pass-through
3 · FY28 onwards
Agri-non-agri mix rebalancing (50-50 target in 4-5 years); capacity debottlenecking
Key risk: agri segment weakness and VCM supply constraints limiting H1 upside.